预测STEMI患者心脏破裂的临床风险评分:开发与验证
该研究纳入中国7个中心11,234例STEMI患者,先用7455例开发简易心脏破裂风险模型,再用另外3779例连续STEMI患者以前瞻性方式通过ROC曲线验证。心脏破裂发生率为2.12%(238/11,234),心脏破裂患者30天死亡率为86%。风险模型包含7项独立基线临床预测因子:女性、高龄、前壁心肌梗死、延迟入院、心率、白细胞计数升高和贫血。风险评分系统可区分STEMI患者心脏破裂发生率从0.2%到13%,验证队列AUC为0.78(95%CI 0.73–0.84)。在高风险组(3.9% vs. 6.2%,p<0.05)和极高风险组(8.0% vs. 15.2%,p<0.05),直接经皮冠状动脉介入治疗降低了心脏破裂发生率。
要点
- 心脏破裂发生率为2.12%(238/11,234),心脏破裂患者30天死亡率为86%。
- 风险评分含7项独立基线预测因子:女性、高龄、前壁心肌梗死、延迟入院、心率、白细胞计数升高、贫血。
- 评分系统区分的心脏破裂发生率范围为0.2%至13%,验证队列AUC为0.78(95%CI 0.73–0.84)。
- 在高风险组(3.9% vs. 6.2%,p<0.05)和极高风险组(8.0% vs. 15.2%,p<0.05),直接PCI降低了心脏破裂发生率。
适用人群与场景
- 中国7个中心的STEMI患者,共11,234例;开发队列7455例,前瞻性验证队列3779例连续STEMI患者。
研究设计与关键结果
- 研究类型:风险评分开发与前瞻性验证研究,纳入中国7个中心11,234例STEMI患者,开发队列7455例,验证队列3779例连续患者。
- 心脏破裂发生率为2.12%(238/11,234),心脏破裂患者30天死亡率为86%。
- 开发的风险模型含7项独立基线临床预测因子:女性、高龄、前壁心肌梗死、延迟入院、心率、白细胞计数升高、贫血。
- 风险评分系统区分STEMI患者心脏破裂发生率范围为0.2%至13%。
- 验证队列AUC为0.78(95%CI 0.73–0.84)。
- 高风险组直接PCI者心脏破裂发生率3.9% vs. 未直接PCI者6.2%(p<0.05);极高风险组直接PCI者8.0% vs. 未直接PCI者15.2%(p<0.05)。
证据类型、等级与局限
- 证据类型:风险评分开发与前瞻性验证研究;试验注册号NCT02484326。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于7项基线临床变量的简易风险评分系统可识别心脏破裂高风险患者,对此类患者可实施适当的治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac rupture (CR) is a fatal complication of ST-elevation myocardial infarction (STEMI) with poor prognosis. The aim of this study was to develop and validate practical risk score to predict the CR after STEMI.
METHODS: A total of 11,234 STEMI patients from 7 centers in China were enrolled in our study, we firstly developed a simplified fast-track CR risk model from 7455 STEMI patients, and then prospectively validated the CR risk model using receiver-operating characteristic (ROC) curves by the other 3779 consecutive STEMI patients. This trial is registered with ClinicalTrials.gov, number NCT02484326.
RESULTS: The incidence of CR was 2.12% (238/11,234), and the thirty-day mortality in CR patients was 86%. We developed a risk model which had 7 independent baseline clinical predictors (female sex, advanced age, anterior myocardial infarction, delayed admission, heart rate, elevated white blood cell count and anemia). The CR risk score system differentiated STEMI patients with incidence of CR ranging from 0.2% to 13%. The risk score system demonstrated good predictive value with area under the ROC of 0.78 (95% CI 0.73-0.84) in validation cohort. Primary percutaneous coronary intervention decreased the incidence of CR in high risk group (3.9% vs. 6.2%, p<0.05) and very high risk group (8.0% vs. 15.2%, p<0.05).
CONCLUSIONS: A simple risk score system based on 7 baseline clinical variables could identify patients with high risk of CR, for whom appropriate treatment strategies can be implemented.
参考来源
- Qian G, Jin RJ, Fu ZH, et al. Development and validation of clinical risk score to predict the cardiac rupture in patients with STEMI. Am J Emerg Med. 2016. PMID: 28132793. doi:10.1016/j.ajem.2016.12.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。